Abstract
Peripheral blood stem cell transplantation (PBSCT) requires a high-flow catheter for adequate cell collection by apheresis and long i.v. support, this is usually achieved by multiple catheters. We analyzed our experience with Mahurkar or Permacath for apheresis and long-term i.v. support in PBSCT, cared for exclusively by an i.v. therapy team. Fifty-six catheters were used in 53 patients that completed PBSCT (28 Permacath and 28 Mahurkar). In 10 patients (19%) the same catheter was used for multiple PBSCT. The average stay was 58.4 days (7–219), Permacath 76.8 days (14–219) and Mahurkar 42 days (7–106). The incidence of infectious complications was 2.2 × 1000 catheter-days (1.7 Permacath and 3.0 Mahurkar); during neutropenia it was 3.7 × 1000 cathether-days. The incidence of thrombosis was 0.9 × 1000 catheter-days. There was a total of seven infectious episodes (12.7%). Five (9%) were local and two were (3.6%) bacteremias. The microorganism most commonly isolated was Staphylococcus sp. (57%). Four catheters (7.1%) were removed because of complications: one thrombosis and three infections. Both catheters have proven useful and safe for long-lasting vascular access in patients undergoing PBSCT. No statistical difference was found in infectious and non-infectious complications between either catheters.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Volkow, P., Téllez, O., Vázquez, C. et al. A single, double lumen high-flow catheter for patients undergoing peripheral blood stem cell transplantation. Experience at the National Cancer Institute in Mexico. Bone Marrow Transplant 20, 779–783 (1997). https://doi.org/10.1038/sj.bmt.1700295
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700295
Keywords
This article is cited by
-
Pseudomonas fluorescens CRBSI outbreak: complying with the standardization of invasive procedures is a step ahead in the fight against antimicrobial resistance
Antimicrobial Resistance & Infection Control (2024)
-
Multi-purpose silastic dual-lumen central venous catheters for both collection and transplantation of hematopoietic progenitor cells
Bone Marrow Transplantation (2000)